跨越国界的治愈：印度的优势——哲学、商业、法律与伦理探讨

HealingBeyond Borders: Philosophical, Business, Legal April 2026 Research HealingBeyondBorders: Philosophical, Business, Legal DMS Code: 150725.1 Ranked as the ‘Most Innovative Indian Law Firm’ in the prestigious FT Innovative Lawyers Asia PacificAwards for multiple years. Also ranked amongst the ‘Most Innovative Asia Pacific Law Firm’ in these Disclaimer This report is a copyright of Nishith Desai Associates. No reader should act on the basis of any statementcontained herein without seeking professional advice. The authors and the firm expressly disclaim all andany liability to any person who has read this report, or otherwise, in respect of anything, and of consequences Contact For any help or assistance please email us onconcierge@nishithdesai.comor visit us atwww.nishithdesai.com. Authors: Shlok Siddhant shlok.siddhant@nishithdesai.com Shlok is a member of the Pharmaceuticals and Life Sciences team at Nishith Desai Associates. Shlok’s work focuses onregulatory, and compliance matters across the pharmaceutical and healthcare sectors. He regularly advices clients ona range of issues including drug and medical device regulations, and marketing and promotional compliance. Naveli Sharmanaveli.sharma@nishithdesai.com Naveli is a member of the Pharmaceuticals and Life Sciences team at Nishith Desai Associates. Naveli Sharma’spractice focuses on advising clients across the healthcare, pharmaceutical, med-tech and life sciences ecosystemon regulatory, compliance and policy-related matters. She regularly works with domestic and international companieson issues relating to drug and medical device regulation, market entry strategies, manufacturing and distribution Tanya Kukade tanya.kukade@nishithdesai.com Tanya Kukade is a member of the pharmaceutical, healthcare, medical device and digital health team at Nishith DesaiAssociates. She has advised numerous multinational pharmaceutical and medical device companies on regulatoryaspects of licensing, price regulation, import, compliance and intellectual property matters. She also has experiencein commercial documentation and litigation matters for pharmaceutical companies, and in public procurement. Dr Milind Antani milind.antani@nishithdesai.com Dr Milind Antani is a renowned surgeon turned lawyer, and heads the pharmaceutical, healthcare, medical deviceand digital health practice at Nishith Desai Associates, as well as the food and beverages practice. He is a recognisedthought-leader within the industry, having authored numerous articles and publications related to the pharma and Contents List of AbbreviationsExecutive Summary Legal and Regulatory Landscape A.Drug Regulatory FrameworkB.Medical Visa & AYUSH VisaC.Regulation of Clinics and HospitalsD.NABH StandardsE.Fertility and Reproductive Tourism Government Schemes and Initiatives A.Union Budget 2026-27B.Market Development Assistance Scheme Jurisdictional Comparison A.United States of America (USA)B.Singapore SWOT Analysis of India’s MVT Sector 25 A.StrengthsB.Weaknesses 25 Advantage India: Why the World Should Choose India A.For International Patients Challenges A.Fragmented Legal FrameworkB.Uneven Quality StandardsC.Infrastructure and Connectivity Constraints Recommendations A.Unified Regulatory FrameworkB.Outreach Beyond Major CitiesC.Strengthening International Insurance Integration Way Forward List of Abbreviations Executive Summary In the recent years, India has emerged as a major destination for international patients seeking high-qualityhealthcare services at comparatively affordable costs. The convergence of healthcare services and the tourismsector has given rise to a growing medical value travel ecosystem, supported by India’s clinical expertise, cost Rising healthcare costs, long waiting periods, and limited access to specialised treatments in several developedcountries have contributed to the growing demand for cross-border medical care. India has respondedto this demand by offering advanced medical procedures across specialties such as cardiology, orthopaedics, This paper examines the evolution of India’s medical tourism sector by analysing market trends, the legaland regulatory framework governing healthcare services accessed by international patients, and governmentinitiatives aimed at strengthening India’s position as a global medical tourism destination. While India The paper concludes by recommending measures to strengthen the ecosystem, including improved regulatorycoordination, wider adoption of quality standards beyond major urban centres, stronger internationalinsurance integration, enhanced infrastructure and patient facilitation services, and a more coordinated Introduction Over the past decade, India has increasingly gained recognition as a destination offering high-quality health-care services at comparatively affordable costs. It remains a key contributor to healthcare-led foreign exchangeinflows, supported by cost competitiveness and cli